¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"General Clinical Research Center"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ciliospinal center
    ¼¶¸ðüô¼öÁßÃß
  • community health center
    Áö¿ªº¸°Ç¼Ò
  • cardioaccelerating center
    ½ÉÀåÃËÁøÁßÃß
  • center
    1. Áß½É, ¼¾ÅÍ 2. ÁßÃß
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
  • center frequency
    Áß½ÉÁ֯ļö
  • chondrification center
    ¿¬°ñ¹ß»ýÁß½É, ¿¬°ñÈ­Áß½É
  • dentary center
    ¾Æ·¡ÅλÀ¹ß»ýÁß½É, ÇϾǰñÇÙ
  • expiratory center
    ³¯¼ûÁßÃß, È£±âÁßÃß
  • ejaculation center
    »çÁ¤ÁßÃß
  • emergency medical center
    ÀÀ±ÞÀÇ·á¼¾ÅÍ
  • erection center
    ¹ß±âÁßÃß
  • feeding center
    ¼·½ÄÁßÃß
  • gaze center
    ÁÖ½ÃÁßÃß
  • genital center
    »ý½ÄÁßÃß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • clinical target volume
    ÀÓ»óÇ¥ÀûüÀû
  • controlled clinical study
    °ü¸®È­ÀÓ»ó½ÃÇè
  • good clinical practice
    ÀǾàǰÀÓ»ó½ÃÇè°ü¸®±âÁØ
  • structured clinical interview
    ±¸Á¶È­ÀÓ»ó¸éÁ¢
  • accelerating center
    ½ÉÀåÃËÁøÁßÃß
  • acoustic center
    û°¢ÁßÃß
  • apneustic center
    Áö¼ÓÈíÀÔÁßÃß
  • association center
    ¿¬ÇÕÁßÃß
  • health center administration
    º¸°Ç¼ÒÇàÁ¤
  • center
    Áß½É, ÁßÃß, ¼¾ÅÍ
  • cardioaccelerating center
    (¢¡accelerating center) ½ÉÀåÃËÁøÁßÃß
  • center frequency
    Áß½ÉÁ֯ļö
  • chondrification center
    ¿¬°ñ¹ß»ýÁß½É
  • ciliospinal center
    ¼¶¸ðüô¼öÁßÃß
  • community health center
    Áö¿ªº¸°Ç¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ankle clonus center
    ¹ß¸ñŬ·Î´©½ºÁßÃß.
  • ganglionic center
    ½Å°æÀýÁß½É, ½Å°æÀýÁßÃß(¡­ñéõÒ).
  • gasping center
    Çæ¶±ÀÓÁßÃß, °¡»ÛÈ£ÈíÁßÃß, °æ·Ã¼º È£ÈíÁßÃß.
  • genital center
    »ý½Ä±âÁßÃß(ßæãÖÐïñéõÒ), ¼º±âÁßÃß(àõÐïñéõÒ).
  • geometrical center
    ±âÇÏÇÐÀû Áß½É.
  • germinal center
    Á¾ÀÚÁß½É, ¹èÁß½É.
  • germinal center
    Á¾ÀÚÁß½É
  • gustatory center
    ¹Ì°¢ÁßÃß(¡­ñéõÒ).
  • gustatory center
    ¹Ì°¢ÁßÃß
  • health center
    º¸°Ç¼Ò(ËÓ˧ËÛ).
  • health center administration
    º¸°Ç¼ÒÇàÁ¤ (ÊÙÌ´Ëø).
  • heat center
    ¿Â¿­ÁßÃß(è®æðñéõÒ).
  • heat regulatory center
    ü¿ÂÁ¶ÀýÁßÃß(¡­ñéõÒ).
  • heating center
    °¡¿ÂÁßÃß(Ê¥è®ñéõÒ).
  • higher center
    °íÀ§ÁßÃß(ÍÔêÈñéõÒ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • general acid
    ÀϹݻê(ìéÚõß«).
  • general adaptation syndrome
    ÀϹÝÀû ÀûÀÀÁõÈıº(ìéÚõîÜîêëëñøý¦ÏØ)
  • general adaptation syndrome =GAS
    ÀϹݼøÀÀÁõÈıº(ìéÚõâ÷ëëñøý¦ÏØ).
  • general alveolar hypoventilation
    (ÀϹÝ)ÆóÆ÷¼º(øËøààõ) Àúȯ±â(î¸üµÑ¨).
  • general alveolar hypoventilation
    (ÀϹÝ)Æó Æ÷¼º Àúȯ±â.
  • general anemia
    Àü½Å¼º ºóÇ÷.
  • general anesthesia
    Àü½Å¸¶Ãë.
  • general anesthetic
    Àü½Å¸¶Ãë¾à.
  • general attitude
    Àü¹ÝÀû ŵµ(îïÚõîÜ÷¾Óø)
  • general base
    ÀϹݿ°±â(ìéÚõç¤Ðñ).
  • general chorea
    Àü½Å¼º ¹«µµº´.
  • general circulation
    ´ë¼øÈ¯(ÓÞâàü»).
  • general circulation
    ´ë¼øÈ¯.
  • general concept
    ÀϹݰ³³ä
  • general condition
    Àü½Å»óÅÂ(îïãóßÒ÷¾).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
DCP dicalcium phosphate; Diploma in Clinical Pathology; Diploma in Clinical Psychology; District Communi...
CDAC Clinical Data Abstraction Center
CEAC clinical education and assessment center
NCCIP National Center for Clinical Infant Program
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LREC Local Research Ethics Committee
M.R.C. Medical Research Council
NHMRC National Health and Medical Research Council
NIDR National Institute of Dental Research
NRC National Research Council
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reflex center
    ¹Ý»ç ÁßÃß
  • rehabilitation center
    ÀçȰ¿ø
  • respiratory center
    È£Èí ÁßÃß
  • rotation center
    ȸÀü Áß½É, ȸÀüÁ¡
    ÇÑ Á¡À¸·Î ÀÌ·ç¾îÁö¸ç ±× Á¡ ÁÖÀ§ÀÇ ¸ðµç ´Ù¸¥ Á¡µéÀº À̰ÍÀ» Áß½ÉÀ¸·Î ¿îµ¿ÇÑ´Ù.
  • satiety center
    Æ÷¸¸ ÁßÃß, ¸¸º¹ ÁßÃß
    »ç»ó ÇϺΠ¿ÜÃøºÎ¿¡ °øº¹ ÁßÃß°¡ ÀÖ°í, ³»ÃøºÎ º¹³»Ãø ÇÙ¿¡ ¸¸º¹ ÁßÃß°¡ Á¸ÀçÇÑ´Ù.
  • secondary ossification center
    ÀÌÂ÷ °ñÈ­ Áß½É
  • sense center
    Áö°¢ ÃæÃß
  • sensory center
    Áö°¢ ÁßÃß
    ´ë³ú ÇÇÁú¿¡ Á¸ÀçÇϸ鼭 °¨°¢¿¡ °ü¿©Çϰí ÀÖ´Â ºÎºÐ. Áö°¢ÀÇ ¼º¸³¿¡´Â °¢ Áö°¢¿¡ ´ëÀÀÇÏ´Â ´ë³ú ÇÇÁúÀÇ Æ¯Á¤ ºÎÀ§ÀÇ ÈïºÐÀÌ ÇÊ¿äÇÏ´Ù. ¶ÇÇÑ, °¢ Áö°¢±â¿¡ ÀϾ´Â Áö°¢ ½Å°æÀº Áö°¢·É¿¡ À̸£±â Àü¿¡ ¹Ýµå½Ã ƯÁ¤ ÇÇÁúÇÏ ÇÙ¿¡¼­ ´º·±
  • sensory speech center
    °¨°¢¼º ¾ð¾î ÁßÃß
    µÎÁ¤¿±ÀÇ ½Ã°¢ ºÎÀ§¿Í û°¢ ºÎÀ§ »çÀÌ¿¡ Á¸ÀçÇÑ´Ù.
  • sleeping center
    ¼ö¸é ÁßÃß
  • temperature regulatory center
    ü¿Â Á¶Àý ÁßÃß
  • thirst center
    °¥Áõ ÁßÃß
  • vasodilator center
    Ç÷°ü È®Àå ÁßÃß
  • visual center
    ½Ã°¢ ÁßÃß
    ÁßÁֽŰæ°è¿¡¼­ ½Ã°¢¿¡ Á÷Á¢ °ü¿©ÇÏ´Â ½Å°æ¼¼Æ÷ Áý´ÜÀ» °¡¸£Å°³ª ¸Á¸·À» Æ÷ÇÔ½ÃŰÁö ¾Ê´Â °ÍÀÌ º¸ÅëÀÌ´Ù.
  • vital center
    »ý¸í À¯Áö ÁßÃß
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
phase I clinical trial <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose.
They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies.
The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs.
(31 Dec 1997)
phase II clinical trial <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study.
(31 Dec 1997)
phase III clinical trial <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments.
Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials.
(31 Dec 1997)
Millon clinical multiaxial inventory A paper and pencil test, consisting of 20 clinical scales derived from 175 self-descriptive statements, and developed in 1977 for use in the assessment of psychopathology and the more enduring patterns of personality; specifically designed to correspond with some of the disorders of personality included in the Diagnostic and Statistical Manual of Mental Disorders used in diagnosis by mental health professionals.
Synonym: Millon clinical multiaxial inventory.
(05 Mar 2000)
Millon Clinical Multiaxial Inventory test A paper and pencil test, consisting of 20 clinical scales derived from 175 self-descriptive statements, and developed in 1977 for use in the assessment of psychopathology and the more enduring patterns of personality; specifically designed to correspond with some of the disorders of personality included in the Diagnostic and Statistical Manual of Mental Disorders used in diagnosis by mental health professionals.
Synonym: Millon clinical multiaxial inventory.
(05 Mar 2000)
clinical 1. Pertaining to a clinic or to the bedside.
2. Pertaining to or founded on actual observation and treatment of patients, as distinguished from theoretical or basis sciences.
(18 Nov 1997)
clinical anatomy The practical application of anatomical knowledge to diagnosis and treatment.
Synonym: applied anatomy.
(05 Mar 2000)
clinical burden A burden that differs from genetic burden mainly in the added component of morbidity; a trait that is neither a clinical or a genetic lethal may be grossly disabling.
(05 Mar 2000)
clinical chemistry The chemistry of human health and disease, chemistry in connection with the management of patients, as in a hospital laboratory.
(05 Mar 2000)
clinical chemistry tests Laboratory tests demonstrating the presence of physiologically significant substances in the blood, urine, tissue, and body fluids with application to the diagnosis or therapy of disease.
(12 Dec 1998)
clinical clerkship Undergraduate medical education programs for second- , third- , and fourth-year students in which the students receive clinical training and experience in teaching hospitals or affiliated health centres.
(12 Dec 1998)
clinical competence The capability to perform acceptably those duties directly related to patient care.
(12 Dec 1998)
clinical conference A conference of physicians on their observations of a patient at the bedside, regarding the physical state, laboratory and other diagnostic findings, clinical manifestations, results of current therapy, etc. A clinical conference usually ends with a confirmation or correction of clinical findings by a pathological diagnosis performed by a pathologist. "clinical conference" is often referred to as a "clinico-pathological conference."
(12 Dec 1998)
clinical cooperative group A group of medical institutions cooperating to perform clinical research.
(16 Dec 1997)
clinical crown That part of the crown of a tooth visible in the oral cavity.
Synonym: corona clinica.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Comptroller General
    (¿¬¹æÁ¤ºÎ)°¨»ç¿øÀå
  • Controller General
    °¨µ¶Àå°ü;°¨»ç¿øÀå
  • Estates General
    =STATES GENERAL
  • General American
    ÀÏ¹Ý ¹Ì±¹ ¿µ¾î(¹Ì±¹ New England Áö¹æ ¹× ³²ºÎ¸¦ Á¦¿ÜÇÑ Àü¿ª¿¡¼­ ÀÏ»ó »ç¿ëµÇ°í ÀÖ´Â ¿µ¾î)
  • General Assembly
    (À¯¿£)ÃÑȸ
  • General Eletcion Day
    ÃѼ±°ÅÀÏ
  • General Gost Office
    ·±´ø Áß¾Ó ¿ìü±¹
  • General Post Office
    Áß¾Ó ¿ìü º»±¹
  • General Services Administration
    Á¶´Þ º»ºÎ
  • General Staff Office
    Âü¸ð º»ºÎ
  • General Winter
    µ¿À屺(ÀÇÀÎÈ­,±º»ç Çൿ¿¡ Å« ¿µÇâÀ» ÁÖ¾ú´Ù)
  • Registrar-General
    (·±´øÀÇ)È£Àû º»¼­ Àå°ü )
  • accountant general
    ȸ°è(°æ¸®)°úÀå;°æ¸®±¹Àå(ºÎÀå)
  • attorney general
    ¹ý¹«Àå°ü
  • captain general
    ÃÑ»ç·É°ü !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á